Ratings AECI Ltd London S.E.

Equities

87FZ

ZAE000000238

Market Closed - London S.E. Other stock markets 09:05:13 16/05/2024 pm IST			5-day change	1st Jan Change
65.75 ^GBX	0.00%		0.00%	0.00%

28/02	Transcript : AECI Ltd, 2023 Earnings Call, Feb 28, 2024
27/02	AECI Ltd Reports Earnings Results for the Full Year Ended December 31, 2023	CI

Summary

The company has strong fundamentals. More than 70% of companies have a lower mix of growth, profitability, debt and visibility.
The company presents an interesting fundamental situation from a short-term investment perspective.

Strengths

The company's earnings per share (EPS) are expected to grow significantly over the next few years according to the consensus of analysts covering the stock.
The equity is one of the most attractive in the market with regard to earnings multiple-based valuation.
The company shows low valuation levels, with an enterprise value at 0.23 times its sales.
The company's share price in relation to its net book value makes it look relatively cheap.
Given the positive cash flows generated by its business, the company's valuation level is an asset.
The company is one of the best yield companies with high dividend expectations.
Over the past year, analysts have regularly revised upwards their sales forecast for the company.
Upward revisions of sales forecast reflect a renewed optimism among the analysts covering the stock.
For the last twelve months, analysts have been gradually revising upwards their EPS forecast for the upcoming fiscal year.
The difference between current prices and the average target price is rather important and implies a significant appreciation potential for the stock.
The average price target of analysts who are interested in the stock has been strongly revised upwards over the last four months.

Weaknesses

The average consensus view of analysts covering the stock has deteriorated over the past four months.
Over the past twelve months, analysts' consensus has been significantly revised downwards.
The group usually releases earnings worse than estimated.

Ratings chart - Surperformance

Sector: Specialty Chemicals

	1st Jan change	Capi.	ESG Refinitiv
AECI LTD	0.00%	554M	-
ECOLAB INC.	+17.29%	66.52B	A-
SIKA AG	+2.81%	50.34B	A-
GIVAUDAN SA	+17.88%	42.01B	B+
FUJIFILM HOLDINGS CORPORATION	+20.88%	26.68B	A-
EMS-CHEMIE HOLDING AG	+11.82%	19.97B	C+
CELANESE CORPORATION	+0.19%	17.32B	B+
POSCO FUTURE M CO., LTD.	-21.87%	15.7B	A-
SYMRISE AG	+0.91%	15.53B	B+
ALBEMARLE CORPORATION	-10.58%	14.99B	C+

Investor Rating

Trading Rating

ESG Refinitiv

Financials

Sales growth

Earnings Growth

EBITDA / Sales

Profitability

Finances

Valuation

P/E ratio

EV / Sales

Price to Book

Price to Free Cash Flow

Yield

Momentum

1 year Revenue revision

4 months Revenue revision

7 days Revenue revision

1 year EPS revision

4 months EPS revision

Consensus

Analyst Opinion

Potential Price Target

4m Target Price Revision

4m Revision of opinion

12m Revision of opinion

Business Predictability

Analyst Coverage

Divergence of Estimates

Divergence of analysts' opinions

Divergence of Target Price

Earnings quality

Technical analysis

ST Timing

MT Timing

LT Timing

RSI

Bollinger Spread

Unusual volumes